Inpatient Rehab And Outpatient Access Improvements Will Secure Success

AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Published
02 Sep 24
Updated
30 Jul 25
AnalystConsensusTarget's Fair Value
US$20.50
38.7% undervalued intrinsic discount
30 Jul
US$12.57
Loading
1Y
-63.2%
7D
-11.9%

Author's Valuation

US$20.5

38.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 May 25
Fair value Decreased 13%

Shared on30 Apr 25
Fair value Increased 0.99%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 1.62%

AnalystConsensusTarget has increased future PE multiple from 14.8x to 16.7x.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.97%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Increased 10%

AnalystConsensusTarget has decreased revenue growth from -2.7% to 6.5%, increased profit margin from 2.4% to 3.8% and decreased future PE multiple from 45.0x to 14.7x.